Valuation : Virbac

Market Cap 263.06Cr 305.96Cr 247.49Cr 225.85Cr 421.48Cr 29TCr 423.66Cr 2.93TCr 1.13TCr 15TCr 1.15TCr 1.12TCr 47TCr P/E 2026 *
15.4x
P/E 2027 * 13.9x
Enterprise Value 275.74Cr 320.7Cr 259.41Cr 236.73Cr 441.79Cr 30TCr 444.07Cr 3.07TCr 1.19TCr 16TCr 1.2TCr 1.18TCr 49TCr EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.64x
Free-Float
49.03%
Yield 2026 *
0.55%
Yield 2027 * 0.65%
1 week-1.24%
Current month-1.24%
1 month-7.67%
3 months-7.94%
6 months-8.00%
Current year-10.14%
1 week 312.5
Extreme 312.5
324.5
1 month 312.5
Extreme 312.5
345
3 years 239
Extreme 239
400
5 years 215.25
Extreme 215.25
447
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%-2.94%-2.30%+20.15% 305.89Cr
-2.97%-4.17%-51.22%-60.15% 3.13TCr
-2.18%+0.48%+26.12%+107.29% 1.22TCr
+2.32%+2.08%-9.82%+7.56% 395.52Cr
+0.64%-2.02%-2.47%+18.35% 305.89Cr
+0.98%-1.58%+52.02%+34.71% 199.72Cr
-0.44%-3.00%+9.66%+17.47% 188.18Cr
-2.27%-2.59%-5.21%+197.33% 155.3Cr
-0.33%+4.74%-16.23%+0.22% 122.99Cr
+2.27%+5.42%-3.23%-37.34% 107.1Cr
Average -0.09%+1.15%-0.27%+30.56% 647.94Cr
Weighted average by Cap. -1.48%-0.35%-20.33%-0.89%

Financials

2026 *2027 *
Net sales 155.09Cr 180.38Cr 145.91Cr 133.16Cr 248.49Cr 17TCr 249.78Cr 1.73TCr 668.86Cr 8.74TCr 677.36Cr 662.56Cr 28TCr 164.73Cr 191.59Cr 154.98Cr 141.43Cr 263.93Cr 18TCr 265.3Cr 1.84TCr 710.42Cr 9.28TCr 719.45Cr 703.74Cr 30TCr
Net income 17Cr 20Cr 16Cr 15Cr 27Cr 1.89TCr 28Cr 190.74Cr 74Cr 964.37Cr 75Cr 73Cr 3.07TCr 19Cr 22Cr 18Cr 16Cr 30Cr 2.09TCr 31Cr 211.28Cr 82Cr 1.07TCr 83Cr 81Cr 3.4TCr
Net Debt 13Cr 15Cr 12Cr 11Cr 20Cr 1.4TCr 20Cr 141.28Cr 55Cr 714.32Cr 55Cr 54Cr 2.27TCr 7.52Cr 8.74Cr 7.07Cr 6.45Cr 12Cr 828.72Cr 12Cr 84Cr 32Cr 423.58Cr 33Cr 32Cr 1.35TCr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Date Price Change
08/26/08 319.00 +1.75%
07/26/07 €313.50 -1.42%
04/26/04 €318.00 -1.47%
03/26/03 €322.75 +0.70%
02/26/02 €320.50 -0.77%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
314.00EUR
Average target price
411.88EUR
Spread / Average Target
+31.17%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!